{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Alzamend Neuro, Inc.
Is Alzamend Neuro, Inc. technically bullish or bearish?
As of June 17, 2025, the technical trend has shifted to a bearish stance, driven by negative signals from moving averages and Bollinger Bands, despite some mild bullish indicators from MACD and RSI.
What does Alzamend Neuro, Inc. do?
Alzamend Neuro, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $1 million and a market cap of $2.38 million. Key financial metrics include a negative P/E ratio, no dividend yield, and a debt-to-equity ratio of -0.97.
How big is Alzamend Neuro, Inc.?
As of Jun 18, Alzamend Neuro, Inc. has a market capitalization of 2.38 million, with net sales of 0.00 million and a net profit of -4.22 million over the last four quarters. As of April 2024, the company's shareholder's funds were -2.59 million, and total assets were 0.63 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
